Literature DB >> 24463557

A novel gene regulator, pyrrole-imidazole polyamide targeting ABCA1 gene increases cholesterol efflux from macrophages and plasma HDL concentration.

Akiko Tsunemi1, Takahiro Ueno, Noboru Fukuda, Takayoshi Watanabe, Kazunobu Tahira, Akira Haketa, Yoshinari Hatanaka, Sho Tanaka, Taro Matsumoto, Yoshiaki Matsumoto, Hiroki Nagase, Masayoshi Soma.   

Abstract

UNLABELLED: Pyrrole-imidazole (PI) polyamides are nuclease-resistant novel compounds that inhibit transcription factors by binding to the minor groove of DNA. A PI polyamide that targets mouse ABCA1 and increases ABCA1 gene expression was designed and evaluated as an agent to increase plasma HDL concentration. A PI polyamide was designed to bind the activator protein-2 binding site of the mouse ABCA1 promoter. The effect of this PI polyamide on ABCA1 expression was evaluated by real-time RT-PCR and Western blotting using RAW264 cells. In vivo effects of this polyamide on ABCA1 gene expression and plasma HDL level were examined in C57B6 mice. One milligram per kilogram of body weight of PI polyamide was injected via the tail veins every 2 days for 1 week, and plasma lipid profiles were evaluated. PI polyamide showed a specific binding to the target DNA in gel mobility shift assay. Treatment of RAW264 cells with 1.0 μM PI polyamide significantly increased ABCA1 mRNA expression. PI polyamide also significantly increased apolipoprotein AI-mediated HDL biogenesis in RAW264 cells. Cellular cholesterol efflux mediated by apolipoprotein AI was significantly increased by the PI polyamide treatment. PI polyamide significantly increased expression of ABCA1 mRNA in the liver of C57B6 mice. Plasma HDL concentration was increased by PI polyamide administration. All of the HDL sub-fractions showed a tendency to increase after PI polyamide administration. The designed PI polyamide that targeted ABCA1 successfully increased ABCA1 expression and HDL biogenesis. This novel gene-regulating agent is promising as a useful compound to increase plasma HDL concentration. KEY MESSAGES: A novel pyrrole-imidazole (PI) polyamide binds to ABCA1. PI polyamide interfered with binding of AP-2ɑ protein to the ABCA1 gene promoter. PI polyamide inhibited the AP-2ɑ-mediated reduction of ABCA1 gene and protein expression. PI polyamide increased ABCA1 protein and apolipoprotein AI mediated HDL biogenesis. PI polyamide is a new gene regulator for the prevention of atherosclerotic diseases.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24463557     DOI: 10.1007/s00109-013-1118-x

Source DB:  PubMed          Journal:  J Mol Med (Berl)        ISSN: 0946-2716            Impact factor:   4.599


  49 in total

1.  The gene encoding ATP-binding cassette transporter 1 is mutated in Tangier disease.

Authors:  M Bodzioch; E Orsó; J Klucken; T Langmann; A Böttcher; W Diederich; W Drobnik; S Barlage; C Büchler; M Porsch-Ozcürümez; W E Kaminski; H W Hahmann; K Oette; G Rothe; C Aslanidis; K J Lackner; G Schmitz
Journal:  Nat Genet       Date:  1999-08       Impact factor: 38.330

Review 2.  Chemical approaches to control gene expression.

Authors:  J M Gottesfeld; J M Turner; P B Dervan
Journal:  Gene Expr       Date:  2000

3.  Cellular localization and trafficking of the human ABCA1 transporter.

Authors:  E B Neufeld; A T Remaley; S J Demosky; J A Stonik; A M Cooney; M Comly; N K Dwyer; M Zhang; J Blanchette-Mackie; S Santamarina-Fojo; H B Brewer
Journal:  J Biol Chem       Date:  2001-05-10       Impact factor: 5.157

Review 4.  Assembly of high density lipoprotein by the ABCA1/apolipoprotein pathway.

Authors:  Shinji Yokoyama
Journal:  Curr Opin Lipidol       Date:  2005-06       Impact factor: 4.776

5.  Transforming growth factor-beta expression in cardiovascular organs in stroke-prone spontaneously hypertensive rats with the development of hypertension.

Authors:  Yoshiko Tahira; Noboru Fukuda; Morito Endo; Ryo Suzuki; Yukihiro Ikeda; Hiroto Takagi; Koichi Matsumoto; Katsuo Kanmatsuse
Journal:  Hypertens Res       Date:  2002-11       Impact factor: 3.872

6.  ABCA1 is the cAMP-inducible apolipoprotein receptor that mediates cholesterol secretion from macrophages.

Authors:  J F Oram; R M Lawn; M R Garvin; D P Wade
Journal:  J Biol Chem       Date:  2000-11-03       Impact factor: 5.157

7.  Helical apolipoproteins stabilize ATP-binding cassette transporter A1 by protecting it from thiol protease-mediated degradation.

Authors:  Reijiro Arakawa; Shinji Yokoyama
Journal:  J Biol Chem       Date:  2002-04-11       Impact factor: 5.157

8.  On the pairing rules for recognition in the minor groove of DNA by pyrrole-imidazole polyamides.

Authors:  S White; E E Baird; P B Dervan
Journal:  Chem Biol       Date:  1997-08

9.  The Prospective Cardiovascular Münster (PROCAM) study: prevalence of hyperlipidemia in persons with hypertension and/or diabetes mellitus and the relationship to coronary heart disease.

Authors:  G Assmann; H Schulte
Journal:  Am Heart J       Date:  1988-12       Impact factor: 4.749

10.  Allosteric inhibition of zinc-finger binding in the major groove of DNA by minor-groove binding ligands.

Authors:  Doan H Nguyen-Hackley; Elizabeth Ramm; Christina M Taylor; J Keith Joung; Peter B Dervan; Carl O Pabo
Journal:  Biochemistry       Date:  2004-04-06       Impact factor: 3.162

View more
  7 in total

Review 1.  The past and presence of gene targeting: from chemicals and DNA via proteins to RNA.

Authors:  T M Geel; M H J Ruiters; R H Cool; L Halby; D C Voshart; L Andrade Ruiz; K E Niezen-Koning; P B Arimondo; M G Rots
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2018-06-05       Impact factor: 6.237

2.  Multispecies study: low-dose tributyltin impairs ovarian theca cell cholesterol homeostasis through the RXR pathway in five mammalian species including humans.

Authors:  Yong Pu; Sarah Pearl; Jeremy Gingrich; Jiongjie Jing; Denny Martin; Carlos A Murga-Zamalloa; Almudena Veiga-Lopez
Journal:  Arch Toxicol       Date:  2019-04-21       Impact factor: 5.153

3.  Strategies to gain novel Alzheimer's disease diagnostics and therapeutics using modulators of ABCA transporters.

Authors:  Jens Pahnke; Pablo Bascuñana; Mirjam Brackhan; Katja Stefan; Vigneshwaran Namasivayam; Radosveta Koldamova; Jingyun Wu; Luisa Möhle; Sven Marcel Stefan
Journal:  Free Neuropathol       Date:  2021-12-13

4.  Relationship between ABCA1 gene polymorphism and lacunar infarction combined with arteriosclerosis in patients.

Authors:  Yao Xu; Zhenqiang Li
Journal:  Exp Ther Med       Date:  2018-06-08       Impact factor: 2.447

Review 5.  Analysis of Low Molecular Weight Substances and Related Processes Influencing Cellular Cholesterol Efflux.

Authors:  Dmitry Y Litvinov; Eugeny V Savushkin; Alexander D Dergunov
Journal:  Pharmaceut Med       Date:  2019-12

Review 6.  Apolipoprotein A1-Related Proteins and Reverse Cholesterol Transport in Antiatherosclerosis Therapy: Recent Progress and Future Perspectives.

Authors:  Xiuting Xu; Zikai Song; Bao Mao; Guoliang Xu
Journal:  Cardiovasc Ther       Date:  2022-01-10       Impact factor: 3.023

7.  Identification of N-benzothiazolyl-2-benzenesulfonamides as novel ABCA1 expression upregulators.

Authors:  Hongtao Liu; Xinhai Jiang; Xinfeng Gao; Wenhua Tian; Chen Xu; Ruizhi Wang; Yanni Xu; Liping Wei; Feng Cao; Wenyan Li
Journal:  RSC Med Chem       Date:  2020-03-11
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.